Pseudomembranous Colitis Surgery Differential Diagnoses

1. Finney JMT. Gastro-enterostomy for cicatrizing ulcer of the pylorus. Johns Hopkins Hosp Bull. 1893. 4:53-55.

2. Hall IC, O'Toole E. Intestinal flora in new-born infants. Am J Dis Child. 1935. 49:390-402.

3. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015 Jan 27. 313 (4):398-408. [QxMD MEDLINE Link].

4. McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008 Oct. 3 (5):563-78. [QxMD MEDLINE Link].

5. Indra A, Lassnig H, Baliko N, Much P, Fiedler A, Huhulescu S, et al. Clostridium difficile: a new zoonotic agent?. Wien Klin Wochenschr. 2009. 121 (3-4):91-5. [QxMD MEDLINE Link].

6. Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery. 2008 May. 143 (5):623-9. [QxMD MEDLINE Link].

7. Mitas L, Svaton R, Skricka T, Kala Z, Penka I, Hanslianov M, et al. Surgical treatment of Clostridium colitides. Acta Chir Iugosl. 2012. 59 (2):63-9. [QxMD MEDLINE Link].

8. Earhart MM. The identification and treatment of toxic megacolon secondary to pseudomembranous colitis. Dimens Crit Care Nurs. 2008 Nov-Dec. 27 (6):249-54. [QxMD MEDLINE Link].

9. Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009 Mar 4. 301 (9):954-62. [QxMD MEDLINE Link].

10. Zheng L, Keller SF, Lyerly DM, Carman RJ, Genheimer CW, Gleaves CA, et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol. 2004 Aug. 42 (8):3837-40. [QxMD MEDLINE Link].

11. Vigna SR. 5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats. Int J Inflam. 2014. 2014:389621. [QxMD MEDLINE Link].

12. McVey DC, Liddle RA, Riggs-Sauthier J, Ekwuribe N, Vigna SR. Inhibition of Clostridium difficile toxin A-induced colitis in rats by APAZA. Dig Dis Sci. 2005 Mar. 50 (3):565-73. [QxMD MEDLINE Link].

13. Vigna SR. Intraluminal Administration of Resiniferatoxin Protects against Clostridium difficile Toxin A-Induced Colitis. Gastroenterol Res Pract. 2017. 2017:8438172. [QxMD MEDLINE Link]. [Full Text].

14. [Guideline] McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19. 66 (7):e1-e48. [QxMD MEDLINE Link]. [Full Text].

15. [Guideline] Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019. 14:8. [QxMD MEDLINE Link]. [Full Text].

16. Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol. 2013 Jul 1. 31 (19):2493-9. [QxMD MEDLINE Link].

17. Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, et al. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007 Mar. 35 (2):131-7. [QxMD MEDLINE Link].

18. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997 Sep. 41 (3):366-70. [QxMD MEDLINE Link]. [Full Text].

19. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013 Apr. 108 (4):500-8. [QxMD MEDLINE Link].

20. Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, et al. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study. Am J Gastroenterol. 2017 Jun. 112 (6):940-947. [QxMD MEDLINE Link].

21. Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015 May. 41 (9):835-43. [QxMD MEDLINE Link].

22. Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015 May 5. 313 (17):1719-27. [QxMD MEDLINE Link].

23. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004 Oct. 47 (10):1620-6. [QxMD MEDLINE Link].

24. Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011 Sep. 254 (3):423-7; discussion 427-9. [QxMD MEDLINE Link].

25. Ahmed N, Kuo YH. Early Colectomy Saves Lives in Toxic Megacolon Due to Clostridium difficile Infection. South Med J. 2020 Jul. 113 (7):345-349. [QxMD MEDLINE Link].

26. Ferrada P, Callcut R, Zielinski MD, Bruns B, Yeh DD, Zakrison TL, et al. Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile-associated disease: An Eastern Association for the Surgery of Trauma multicenter trial. J Trauma Acute Care Surg. 2017 Jul. 83 (1):36-40. [QxMD MEDLINE Link].

27. Shellito AD, Russell MM. Diverting Loop Ileostomy for Clostridium Difficile Colitis: A Systematic Review and Meta-analysis. Am Surg. 2020 Oct. 86 (10):1269-1276. [QxMD MEDLINE Link].

28. Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, et al. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 Jan 26. 376 (4):305-317. [QxMD MEDLINE Link]. [Full Text].

Said Fadi Yassin, MD Associate Professor of Surgery, Department of Cardiothoracic Surgery, University of New Mexico School of Medicine

Said Fadi Yassin, MD is a member of the following medical societies: Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Amy L Friedman, MD Professor of Surgery, Director of Transplantation, State University of New York Upstate Medical University

Amy L Friedman, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Medical Women's Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, American Society of Transplantation, Association for Academic Surgery, Association of Women Surgeons, International College of Surgeons, International Liver Transplantation Society, New York Academy of Sciences, Pennsylvania Medical Society, Philadelphia County Medical Society, Society of Critical Care Medicine, Transplantation Society

Disclosure: Nothing to disclose.

John Geibel, MD, MSc, DSc, AGAF Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, Professor, Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital; American Gastroenterological Association Fellow; Fellow of the Royal Society of Medicine

John Geibel, MD, MSc, DSc, AGAF is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

H Scott Bjerke, MD, FACS Clinical Associate Professor, Department of Surgery, University of Missouri-Kansas City School of Medicine; Medical Director of Trauma Services, Research Medical Center; Clinical Professor, Department of Surgery, Kansas City University of Medicine and Biosciences

H Scott Bjerke, MD, FACS is a member of the following medical societies: American Association for the History of Medicine, American Association for the Surgery of Trauma, American College of Surgeons, Midwest Surgical Association, Royal Society of Medicine, Eastern Association for the Surgery of Trauma, Association for Academic Surgery, National Association of EMS Physicians, Pan-Pacific Surgical Association, Southwestern Surgical Congress, Wilderness Medical Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article